These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7282106)

  • 1. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M; Menning H; Ströbel G
    Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and limits of D-penicillamine therapy].
    Behrend T; Eisterhues C; Behrend M
    Z Rheumatol; 1988; 47 Suppl 1():28-33. PubMed ID: 3213269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [D-penicillamine--side effects, pathogenesis and decreasing the risks].
    Grasedyck K
    Z Rheumatol; 1988; 47 Suppl 1():17-9. PubMed ID: 3063003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of D-penicillamine therapy in Japan.
    Kashiwazaki S
    Z Rheumatol; 1988; 47 Suppl 1():38-40. PubMed ID: 3213270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases].
    Krüger K
    Z Rheumatol; 1995; 54(2):89-95. PubMed ID: 7793161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis.
    Partsch G; Tausch G; Neuwirth E; Neumüller J
    Z Rheumatol; 1983; 42(3):126-9. PubMed ID: 6880413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acadione, a new long-term treatment of rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A
    Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):462-6. PubMed ID: 3393845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine].
    Renier JC; Bontoux-Carre E; Racineux JL
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):25-6. PubMed ID: 3704508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A chemically induced polyneuropathy in chronic polyarthritis treated with D-penicillamine?].
    Mayr N; Graninger W; Wessely P
    Wien Klin Wochenschr; 1983 Feb; 95(3):86-8. PubMed ID: 6305039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.